Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer

In the BioRAIDs cervical-cancer cohort, HPV E7 ctDNA was the most sensitive serum marker; complete clearance by the end of treatment was associated with longer PFS, and patients with persistent HPV ctDNA relapsed at a median of 10 months from first detection.

Clin Cancer ResPubMed 34210686DOI 10.1158/1078-0432.CCR-21-0625